Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
This grant funds the validation of biomarker assays developed through NIH-supported research.
About this program
The Revision Applications for Validation of Biomarker Assays grant is designed to support researchers in the validation of biomarker assays that have been developed through previous NIH-supported research grants. This funding opportunity aims to enhance the reliability and applicability of these assays in clinical settings. It is particularly relevant for researchers who have made significant advancements in biomarker development and are seeking to further validate their findings through rigorous testing and evaluation. Eligible applicants include institutions and organizations that have previously received NIH funding for biomarker research. The grant encourages collaboration among researchers and institutions to ensure that the assays are validated effectively. The validation process is crucial for ensuring that these biomarkers can be reliably used in clinical trials and patient care, ultimately contributing to advancements in healthcare and treatment options.
Eligibility
Eligible applicants include institutions and organizations that have previously received NIH funding for biomarker research.